ACTA1 and chronic obstructive pulmonary disease: Recently, Zhu et al. have shown that N-acetylcysteine, an antioxidant and mucolytic agent, was able to reduce α-SMA levels, collagen volume, wall thickness and bronchioles diameter in a COPD rat model.